Centogene N.V. (CNTGF)
OTCMKTS · Delayed Price · Currency is USD
0.1017
+0.0017 (1.70%)
Oct 31, 2025, 1:38 PM EDT
Centogene Revenue
In the year 2023, Centogene had annual revenue of 48.54M EUR with 2.24% growth. Centogene had revenue of 23.91M in the half year ending December 31, 2023, a decrease of -221.89%.
Revenue
48.54M EUR
Revenue Growth
+2.24%
P/S Ratio
0.06
Revenue / Employee
126.40K EUR
Employees
384
Market Cap
2.98M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 48.54M | 1.06M | 2.24% |
| Dec 31, 2022 | 47.47M | 5.24M | 12.40% |
| Dec 31, 2021 | 42.23M | 3.78M | 9.83% |
| Jan 1, 2021 | 38.45M | -10.33M | -21.17% |
| Dec 31, 2019 | 48.78M | 8.30M | 20.51% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |